Alterity Therapeutics Ltd (NASDAQ:ATHE) Q2 2021 Earnings Conference Call February 25, 2021 5:00 PM ET Company Participants David Stamler - CEO, Chief Medical Officer & SVP, Clinical Development Kathryn Andrews - CFO Conference Call Participants Operator Good morning, and welcome to the Alterity Therapeutics H1 Financial Results and Business update. [Operator Instructions]. Today's call is being recorded. And I'd like to introduce you to our host, Dr. David Stamler, Alterity Therapeutics Chief Executive Offi ...